MedTrace Logo

Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

NCT05866029 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2478

Last updated 2026-01-12

No results posted yet for this study

Summary

This project anchors osteoporotic fractures, conduct registration and follow-up studies, and conduct prospective treatment studies. By registering for follow-up studies on osteoporotic fractures, it is planned to obtain epidemiological data through registration and follow-up studies; A prospective treatment study for patients with osteoporotic fractures is planned to explore effective treatment strategies through randomized controlled trials; To study biomarkers for osteoporotic refractures, we plan to establish a biomarker warning model through multi omics research; To study imaging biomarkers for osteoporotic refractures, a new imaging technology is proposed to establish an imaging omics warning model.

Conditions

  • Osteoporotic Fractures

Interventions

DRUG

Denosumab

Active Comparator: 60mg of Denosumab treatment by subcutaneous injection

DRUG

Teriparatide

Teriparatide was sequentially treated with Denosumab

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Weibo Xia, MD. · Peking Union Medical College Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-26
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05866029 on ClinicalTrials.gov